Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RGS2 |
| Upstream (Parents) |
|---|
| (<<) SELL → RGS2 |
| (<<) FCGR3B → RGS2 |
| (<<) MNDA → RGS2 |
| (<<) SRGN → RGS2 |
| Downstream (Children) |
|---|
| RGS2 → APOBEC3A (>>) |
| RGS2 → MSTN (>>) |
| RGS2 → DGKB (>>) |
| RGS2 → TAP2 (>>) |
| RGS2 → DDX28 (>>) |
| RGS2 → RGS17 (>>) |
| RGS2 → AMACR (>>) |
| RGS2 → FRMD1 (>>) |
| RGS2 → HSPA6 (>>) |
| RGS2 → FOLR3 (>>) |
| RGS2 → FAM155B (>>) |
| RGS2 → SLC25A23 (>>) |
| RGS2 → UTF1 (>>) |
